Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
about
Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a novel nucleotide phosphodiesterase regulated by cholesterol in human macrophagesThe Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of AtherosclerosisControl of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosisModified lipoprotein-derived lipid particles accumulate in human stenotic aortic valves.Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens AitApolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregationAbsorption and lipoprotein transport of sphingomyelin.Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat dietPresecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality controlCharacterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progressionSize-selective uptake of colloidal low density lipoprotein aggregates by cultured white blood cellsSyndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.Molecular biology of atherosclerosis.Hyperlipoproteinemia type 3: the forgotten phenotype.Glycosyltransferases, glycosylation and atherosclerosis.The emerging role of acid sphingomyelinase in autophagy.Automated measurement method for the determination of vitamin E in plasma lipoprotein classes.Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH.Adeno-associated virus-mediated expression of acid sphingomyelinase decreases atherosclerotic lesion formation in apolipoprotein E(-/-) mice.Metabolic syndrome and type 2 diabetes: lipid and physiological consequences.Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.Contribution of p62/SQSTM1 to PDGF-BB-induced myofibroblast-like phenotypic transition in vascular smooth muscle cells lacking Smpd1 gene
P2860
Q28118272-E37B30FF-374D-425B-B0D3-E0004FD73DA1Q33838927-732602EB-E36B-456B-9632-649C7FC740CEQ34412400-1E1AB050-A29E-489D-BB20-24C58A626CB2Q34770283-5BEF4FCF-99A3-49AF-83CE-1BF7ADF161F2Q35155508-7589FF8F-0E11-4F9D-9A56-54B279B873BBQ35642920-A4A32299-DF33-4E39-9527-FB5931FE0403Q36298122-1C1757CC-6987-43E0-A5DE-DBFDB6F9FC8CQ36330432-2D7CE189-7BA3-4597-9F04-336A1E9CE466Q36558102-0358F018-CF97-4970-AF67-7C41BA85E4DFQ36580339-8FA2E7D7-7772-4716-90E9-5370CABCEA4CQ36924524-25992175-8E4D-45E7-9F92-0303C11F280FQ37036917-E91395FD-1672-48FA-9C8A-20A4EAC156A9Q37130793-861DC534-B6F3-45E6-A07C-AFFCB6248290Q37317424-E1E0B716-5950-4E03-8859-AE937CB4D53FQ38125279-6C7890E8-31FD-4C5B-9049-D6B663BED2ADQ38235600-26B9BE6A-DABB-4A0F-8464-DB557A618A28Q38258044-81F4312E-C9E9-4B1F-8128-45745E212801Q38349925-81E6A047-7D52-47EA-B611-71994629454EQ41952558-134B899A-683C-4D74-BAC3-046129691AD1Q42264333-59715A13-54C7-4E3E-864E-00202616179EQ45365704-F80D2221-3A96-4DAC-B846-4DAB0865BD30Q46952304-2DBD1CD5-54FB-49DD-BCC5-0054BEB32D77Q47352273-CD867F7B-527B-4D82-92A5-138244E31899Q59126374-15BAD920-483F-4877-8B0A-F34608CCAD68
P2860
Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Sphingomyelinase induces aggre ...... human arterial proteoglycans.
@en
Sphingomyelinase induces aggre ...... human arterial proteoglycans.
@nl
type
label
Sphingomyelinase induces aggre ...... human arterial proteoglycans.
@en
Sphingomyelinase induces aggre ...... human arterial proteoglycans.
@nl
prefLabel
Sphingomyelinase induces aggre ...... human arterial proteoglycans.
@en
Sphingomyelinase induces aggre ...... human arterial proteoglycans.
@nl
P2093
P1476
Sphingomyelinase induces aggre ...... human arterial proteoglycans.
@en
P2093
Mika Ala-Korpela
Petri T Kovanen
Pirjo Posio
P304
P356
10.1161/01.ATV.0000168912.42941.60
P407
P577
2005-05-05T00:00:00Z